News
03.12.24
ERC: two researchers from San Raffaele-Telethon institute for gene therapy in Milan each receive 2 million euros for their prestigious funding together with IRCCS Ospedale San Raffaele and Università Vita-Salute San Raffaele
Daniela Cesana and Alessio Cantore presented two projects, respectively to investigate the impact, safety and efficacy of gene therapy through the 'signatures' of circulating DNA and to investigate the biology of liver cells in order to exploit them in the field of gene therapy.
28.11.24
Gene therapy: target liver
At the San Raffaele-Telethon Institute in Milan, an innovative liver-directed gene transfer platform applicable to various metabolic diseases has been developed thanks to the efforts of the research group led by Alessio Cantore, together with the biotech company Genespire.
18.11.24
Mucopolysaccharidosis 6 and gene therapy: present and future
A study just published by TIGEM researchers shows how the efficacy of this experimental therapy is maintained over time, at the highest doses. Study coordinator Brunetti-Pierri reports on possible future developments
16.09.24
Naples, world's first genere therapy for a rare retinal disease
The surgery, performed at AOU Vanvitelli, was made possible by an innovative gene therapy platform developed by Pozzuoli's TIGEM that allows for large gene transfer.
05.09.24
ERC Funding, European Research Council: 1.5 million euros each awarded to the projects of three young researchers from Telethon Institutes
Fondazione Telethon has announced that ERC, the European Research Council, has awarded three researchers from the Telethon Institutes three grants of EUR 1.5 million each for five years. Specifically, the three researchers are Samuele Ferrari and Attya Omer from the San Raffaele-Telethon Institute for Gene Therapy (SR-TIGET) in Milan and Ivana Trapani from the Telethon […]
10.07.24
Fondazione Telethon Board of Directors chaired by Luca di Montezemolo appoints Ilaria Villa as new Managing Director
Fondazione Telethon Board of Directors chaired by Luca di Montezemolo appoints Ilaria Villa as new Managing Director. Francesca Pasinelli leaves her executive roles but will remain on the Board of Fondazione Telethon.
15.04.24
New leadership at TIGEM: Alberto Auricchio appointed as director at the Telethon Institute of Genetics and Medicine in Pozzuoli (NA)
A new chapter in a 30-year history: passing on the torch is Andrea Ballabio, who directed the Institute since its foundation in 1994.
28.02.24
Fondazione Telethon announces commitment to make gene therapy for Wiskott-Aldrich syndrome available to patients
On the eve of the 26th World Rare Disease Day, Fondazione Telethon announces its commitment to ensure that gene therapy for Wiskott-Aldrich syndrome (WAS), a rare genetic disease of the immune system, will be available in the next future.
12.09.23
Fondazione Telethon and Orchard Therapeutics complete transfer of marketing authorization of Strimvelis for ADA-SCID in Europe
Una nuova sfida per Telethon, che amplia i confini della propria missione
